This is AI generated summarization, which may have errors. For context, always refer to the full article.
The Philippines has granted emergency use authorization (EUA) for Russia’s Sputnik Light vaccine, Food and Drug Administration (FDA) Director General Eric Domingo confirmed to Rappler on Monday, August 23.
In a text message, Domingo said the EUA was approved on Friday, August 20.
The Sputnik Light vaccine is a human adenoviral vector platform vaccine made by Russian firm Gamaleya. It is a single-dose vaccine like the Janssen vaccine, which was previously the only single-dose vaccine approved for emergency use in the Philippines.
According to the Russian Direct Investment Fund, Sputnik Light has an efficacy of 79.4%. Its cold storage temperature requirement is 2ºC to 8ºC.
Sputnik Light is different from Sputnik V, which is also manufactured by Gamaleya. Sputnik V, a two-dose vaccine, was earlier approved for emergency use and has already been rolled out for jabs.
So far, the Philippines has not announced any orders for doses of Sputnik Light.
The emergency approval gives the Philippine government another option for procuring vaccines as it aims to vaccinate 70 million Filipinos by the end of 2021 in order to achieve herd immunity. The country has so far inoculated 30 million with at least one dose of a COVID-19 vaccine. – Rappler.com